Synthetic Biologics Inc
Change company Symbol lookup
Select an option...
SYN Synthetic Biologics Inc
$RDM.EU FT DJ SL MIC EU
ABQQ Ab International Group Corp
ABLT American Biltrite Inc
ABIO ARCA Biopharma Inc
ABG Asbury Automotive Group Inc
ABEO Abeona Therapeutics Inc
ABDC Alcentra Capital Corp
ABCB Ameris Bancorp
ABBY Abby Inc
Go

Health Care : Biotechnology | Small Cap GrowthCompany profile

Synthetic Biologics, Inc. is a clinical-stage company. The Company is engaged in developing therapeutics to protect the gut microbiome while targeting pathogen-specific diseases. The Company's lead product candidates in Phase II development are SYN-010, which is intended to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C), and SYN-004, which is designed to protect the gut microbiome (gastrointestinal (GI) microflora) from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD). Its other product candidates include SYN-007, SYN-006, SYN-005, SYN-200 and SYN-020. The Company is also developing preclinical-stage monoclonal antibody therapies for the prevention and treatment of pertussis, and discovery-stage biotherapeutics for the treatment of phenylketonuria (PKU).

Closing Price
$0.6227
Day's Change
-0.0173 (-2.70%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.64
Day's Low
0.62
Volume
(Light)
Volume:
70,177

10-day average volume:
177,237
70,177
  • Prev Close
    0.64
  • Today's Open
    0.6244
  • Day's Range
    0.62-0.64
  • Avg Vol (10-day)
    177.2K
  • Last (time)
    8:00p ET 02/15/19
  • Last (size)
    10
  • 52-Wk Range
    0.508 - 15.75
    LowHigh
  • (02/21/18 - 12/27/18)
    22.58%
  • 107.6%
  • Market Cap
    8.4M
  • Shares Outstanding
    13.5M
  • 3.89
  • 0.16x
  • No dividend
  • Ex-dividend
    No dividend
  • 2.5
  • 27.36
  • (% of float 01/31/19)
    2.98

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.